Fortitude Family Office’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fortitude Family Office's PFE Position: Q2 2026 in Review
Fortitude Family Office reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $3.87K and leaving 1,243 shares worth $29.9K. The position accounts for 0.01% of the portfolio, ranked #408.
Fortitude Family Office first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $398K in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fortitude Family Office held 1,243 shares of Pfizer worth $29.9K as of Q2 2026.
- Fortitude Family Office sold 148 Pfizer shares in Q2 2026, an estimated $3.87K.
- Pfizer made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #408 holding.
- Fortitude Family Office first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
- Fortitude Family Office's Pfizer position peaked at $398K in Q3 2024.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.